The subjective assessment of cataract

D B Elliott1, J Gilchrist, M Hurst

  • 1University of Bradford Clinical Vision Research Unit, Optometry Department, University of Bradford, UK.

Insights

Medical treatment for cataracts is becoming a reality with new drugs like Bendalina. This study details six subjective tests, including visual acuity and glare sensitivity, to accurately measure cataract progression during clinical trials.

Area of Science:

  • Ophthalmology
  • Clinical Pharmacology

Background:

  • Cataract treatment is evolving, with medical interventions showing promise.
  • Several anti-cataract drug formulations are undergoing clinical evaluation.

Purpose of the Study:

  • To present six subjective methods for assessing cataract progression in a clinical trial.
  • To evaluate the efficacy of the anti-cataract drug Bendalina.

Main Methods:

  • Refractive error measurement
  • LogMAR visual acuity testing
  • Contrast sensitivity assessment
  • Glare sensitivity testing
  • Retinal visual acuity measurement
  • Displacement threshold hyperacuity evaluation

Main Results:

  • The study outlines the application and rationale for each of the six subjective assessment techniques.
  • Detailed explanations of measurement methodologies are provided for each test.

Conclusions:

  • Accurate assessment of cataract progression is crucial for evaluating anti-cataract drug efficacy.
  • The presented subjective methods provide a comprehensive approach to monitoring cataract development in clinical trials.